Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome
about
Serum Vitamin D Levels and Polycystic Ovary syndrome: A Systematic Review and Meta-AnalysisEndothelial progenitor cell dysfunction in polycystic ovary syndrome: implications for the genesis of cardiovascular diseasesRelevance of vitamin D in reproductionVitamin D Decreases Serum VEGF Correlating with Clinical Improvement in Vitamin D-Deficient Women with PCOS: A Randomized Placebo-Controlled Trial.The effect of calcium and vitamin D supplementation on menstrual cycle, body mass index and hyperandrogenism state of women with poly cystic ovarian syndrome.Antioxidants and management of polycystic ovary syndrome in Iran: A systematic review of clinical trials.Effect of vitamin D supplementation on insulin kinetics and cardiovascular risk factors in polycystic ovarian syndrome: a pilot study.High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial.Effect of vitamin D on biochemical parameters in polycystic ovary syndrome women: a meta-analysis.Males with low serum levels of vitamin D have lower pregnancy rates when ovulation induction and timed intercourse are used as a treatment for infertile couples: results from a pilot study.Focus on metabolic and nutritional correlates of polycystic ovary syndrome and update on nutritional management of these critical phenomena.Role Of Vitamin D And Adipose Tissue Hormones In Women With Reproductive Disorders.Magnesium-Zinc-Calcium-Vitamin D Co-supplementation Improves Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial.Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review.Vitamin D Status Relates to Reproductive Outcome in Women With Polycystic Ovary Syndrome: Secondary Analysis of a Multicenter Randomized Controlled TrialEffect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome.Magnesium-zinc-calcium-vitamin D co-supplementation improves glycemic control and markers of cardio-metabolic risk in gestational diabetes: a randomized, double-blind, placebo-controlled trial.Predictors of depression in women with polycystic ovary syndrome.The effect of Vitamin D supplementation on hormonal and glycaemic profile of patients with PCOS: A meta-analysis of randomised trials.Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients.Correlation between follicular fluid levels of sRAGE and vitamin D in women with PCOS.New Therapeutic Approaches in Obesity and Metabolic Syndrome Associated with Polycystic Ovary Syndrome.The effects of vitamin D plus calcium supplementation on metabolic profiles, biomarkers of inflammation, oxidative stress and pregnancy outcomes in pregnant women at risk for pre-eclampsia.Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial.Effect of vitamin D on clinical and biochemical parameters in polycystic ovary syndrome women: A meta-analysis.Menstrual cycle rhythmicity: metabolic patterns in healthy women
P2860
Q26824831-2918CB5F-498E-4D3E-9321-9100EDE30AE8Q26851688-374F2962-E47A-46FA-A0D9-73404587E69FQ26859233-65925615-53C0-4CBB-8207-C38D504D1041Q33616612-4F3AAE67-8A1D-4758-91AF-47E2D8D41D6AQ34716045-9C32B74F-8CFD-4550-A461-D273635CDB30Q35015466-65BEC9AA-18BD-4A36-829D-1EFE68EC5F2DQ35575366-00713E86-5EED-4850-973E-D7B1A20F591AQ35955786-995B18EC-4A51-4E1C-8BD5-C11D06D40379Q36216981-C49F5DE5-E09E-4526-ADA3-BB16B1E0B234Q36304229-2B94D305-550C-4609-9D72-78D2E05138A2Q38247074-5CFC7E24-32ED-478C-874B-C271A0402FACQ38597808-3EA33C81-CB1D-46FB-AA7B-2073BF137B32Q38698220-5304B0F0-5EBC-4FEF-AB57-019DF51AFC9AQ39106136-1FE972EB-71BC-4641-B07A-22608BD40D64Q39760750-3DB6746D-A349-4DA3-9837-0914C631F035Q47163720-9BCEB47F-CBF7-4C95-8881-8ADF47833BD4Q47188507-A94A9F86-ECBF-4425-9E0B-9DC371571A8EQ48031086-BD962828-0486-45E6-BC7B-4448590F7747Q48121799-0D2F092E-0D91-4FF0-A92F-74013C21EE51Q48377979-D0D4C1A0-07E2-4302-93DA-E80F8198343CQ48514821-07B6154C-6C35-4D70-BCC6-6FF2A628C1FFQ49771912-DB776122-C8BC-4049-8D18-EF4C6EF3181EQ51295509-681F28DE-CA91-48A3-A29F-90E63FF8F757Q51300676-31E1ABD0-C2ED-4205-BC0B-B34FDBD178ADQ53817805-B5C72775-7CFC-4CC1-B51A-E08B55DF5D85Q57062557-C9C3FB52-7BB3-48B7-8DC4-DBF0FCCB8C1B
P2860
Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 July 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic implications of vi ...... with polycystic ovary syndrome
@en
Therapeutic implications of vi ...... ith polycystic ovary syndrome.
@nl
type
label
Therapeutic implications of vi ...... with polycystic ovary syndrome
@en
Therapeutic implications of vi ...... ith polycystic ovary syndrome.
@nl
prefLabel
Therapeutic implications of vi ...... with polycystic ovary syndrome
@en
Therapeutic implications of vi ...... ith polycystic ovary syndrome.
@nl
P2093
P2860
P921
P1476
Therapeutic implications of vi ...... with polycystic ovary syndrome
@en
P2093
Amber Berry
Cheryl Danton
Erin Kustan
Hugh Taylor
Julia Shaw
Luisa Coraluzzi
P2860
P304
P356
10.3109/09513590.2012.696753
P577
2012-07-11T00:00:00Z